The H274Y mutation in the influenza A/H1N1 neuraminidase active site following oseltamivir phosphate treatment leave virus severely compromised both in vitro and in vivo
- 14 May 2002
- journal article
- Published by Elsevier BV in Antiviral Research
- Vol. 55 (2), 307-317
- https://doi.org/10.1016/s0166-3542(02)00053-0
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Selection of Influenza Virus Mutants in Experimentally Infected Volunteers Treated with OseltamivirThe Journal of Infectious Diseases, 2001
- Resistance of influenza viruses to neuraminidase inhibitors — a reviewAntiviral Research, 2000
- In Vitro Selection and Characterisation of Influenza B/Beijing/1/87 Isolates with Altered Susceptibility to ZanamivirVirology, 1999
- Use of the Oral Neuraminidase Inhibitor Oseltamivir in Experimental Human InfluenzaJama-Journal Of The American Medical Association, 1999
- Evidence for Zanamivir Resistance in an Immunocompromised Child Infected with Influenza B VirusThe Journal of Infectious Diseases, 1998
- Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza InfectionAntimicrobial Agents and Chemotherapy, 1998
- Influenza Neuraminidase Inhibitors Possessing a Novel Hydrophobic Interaction in the Enzyme Active Site: Design, Synthesis, and Structural Analysis of Carbocyclic Sialic Acid Analogues with Potent Anti-Influenza ActivityJournal of the American Chemical Society, 1997
- Generation and Characterization of an Influenza Virus Neuraminidase Variant with Decreased Sensitivity to the Neuraminidase-Specific Inhibitor 4-Guanidino-Neu5Ac2enVirology, 1995
- Clinical and epidemiological importance of influenza a viruses resistant to amantadine and rimantadineReviews in Medical Virology, 1992
- Site-directed mutation of the active site of influenza neuraminidase and implications for the catalytic mechanismBiochemistry, 1987